Status:

RECRUITING

AM vs PM Exercise Training

Lead Sponsor:

Michigan State University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Hypertension

Eligibility:

FEMALE

55-80 years

Phase:

NA

Brief Summary

The treatment of high blood pressure, or hypertension, is multifaceted and can include pharmacological therapies (i.e., medications) and lifestyle modifications such as physical activity. Chronotherap...

Detailed Description

Blood pressure has an internal rhythm associated with the 24-hr clock. Nocturnal blood pressure (BP) is a key contributor to cardiovascular health and may be improved by exercise. Moreover, the time o...

Eligibility Criteria

Inclusion

  • Systolic BP equal to or greater than 130 mmHg without BP medication or greater than 120 mmHg with medication and diastolic blood pressure equal to and greater than 80 mmHg
  • 55-80 years old
  • Post-menopausal female
  • Able to walk without assistance

Exclusion

  • Habitually physically active defined as 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic physical activity per week
  • Overt pulmonary disease/condition as follows: chronic bronchitis, chronic obstructive pulmonary disease, emphysema, or pulmonary hypertension
  • Cardiometabolic disease/condition as follows: diabetes, heart failure, peripheral arterial disease, stroke, coronary artery disease, renal disease, secondary hypertension, chronic venous insufficiency or deep vein thrombosis within last 6 months
  • Cancer within last 5 years
  • Body mass index \>39 kg/m2
  • Current smoking or vape
  • Evening shift work
  • uncontrolled thyroid disorder
  • 2 or more falls in the last year
  • Anemia within 3 months of enrollment
  • Parkinson's disease
  • Dementia
  • Unstable angina
  • Acute pulmonary embolus or infarction
  • Acute myocarditis or pericarditis
  • Acute aortic dissection

Key Trial Info

Start Date :

June 11 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2027

Estimated Enrollment :

79 Patients enrolled

Trial Details

Trial ID

NCT06042439

Start Date

June 11 2024

End Date

July 1 2027

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Michigan State University

East Lansing, Michigan, United States, 48824